糖尿病肾病管理的最新进展与尚存挑战
Recent Advances and Remaining Challenges in the Management of Diabetic Kidney Disease.
作者信息
Gervasini Guillermo
机构信息
Department of Medical and Surgical Therapeutics, Medical School, Institute of Molecular Pathology Biomarkers, University of Extremadura, 06005 Badajoz, Spain.
出版信息
J Clin Med. 2023 Apr 7;12(8):2759. doi: 10.3390/jcm12082759.
Abstract
Diabetic kidney disease (DKD), which refers to pathologic structural and functional changes observed in the kidneys of patients with diabetes mellitus (DM), is the greatest contributor to CKD and the most common cause of end-stage kidney disease (ESKD) worldwide [...].
摘要
糖尿病肾病（DKD）是指在糖尿病（DM）患者肾脏中观察到的病理结构和功能变化，是导致慢性肾脏病（CKD）的最大因素，也是全球终末期肾病（ESKD）最常见的病因[……]
相似文献
1
Recent Advances and Remaining Challenges in the Management of Diabetic Kidney Disease.糖尿病肾病管理的最新进展与尚存挑战
J Clin Med. 2023 Apr 7;12(8):2759. doi: 10.3390/jcm12082759.
2
Diabetic kidney disease in Australia: current burden and future projections.澳大利亚的糖尿病肾病：当前负担与未来预测
Nephrology (Carlton). 2014 Aug;19(8):450-8. doi: 10.1111/nep.12281.
3
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.成人糖尿病肾病高血糖管理的临床实践指南
Diabet Med. 2022 Apr;39(4):e14769. doi: 10.1111/dme.14769. Epub 2022 Jan 26.
4
Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.分析糖尿病及肾脏病变患者尿液的拉曼光谱差异。
PeerJ. 2023 Feb 27;11:e14879. doi: 10.7717/peerj.14879. eCollection 2023.
5
Re-understanding and focusing on normoalbuminuric diabetic kidney disease.重新认识并关注正常白蛋白尿的糖尿病肾脏疾病。
Front Endocrinol (Lausanne). 2022 Dec 2;13:1077929. doi: 10.3389/fendo.2022.1077929. eCollection 2022.
6
Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.糖尿病作为慢性肾脏病的病因或合并症及其预后：Gonryo研究
Clin Exp Nephrol. 2018 Apr;22(2):328-336. doi: 10.1007/s10157-017-1451-4. Epub 2017 Jul 27.
7
Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease.高尿酸血症与糖尿病并存时，相较于二者单独存在，会使慢性肾脏病患者的全因死亡率和终末期肾病风险升高。
BMC Nephrol. 2022 Apr 22;23(1):157. doi: 10.1186/s12882-022-02755-1.
8
GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists.胰高血糖素样肽-1受体激动剂与糖尿病肾病：呼吁肾脏病学家予以关注
J Clin Med. 2020 Mar 30;9(4):947. doi: 10.3390/jcm9040947.
9
Comparison of Supersonic Shear Wave Imaging-Derived Renal Parenchyma Stiffness Between Diabetes Mellitus Patients With and Without Diabetic Kidney Disease.糖尿病肾病患者与非糖尿病肾病患者的超声剪切波弹性成像技术评估的肾脏实质硬度比较。
Ultrasound Med Biol. 2020 Jul;46(7):1630-1640. doi: 10.1016/j.ultrasmedbio.2020.03.026. Epub 2020 May 11.
10
Can we cure diabetic kidney disease? Present and future perspectives from a nephrologist's point of view.我们能治愈糖尿病肾病吗？从肾病学家的角度看现状与未来前景。
J Intern Med. 2022 Feb;291(2):165-180. doi: 10.1111/joim.13424. Epub 2021 Dec 22.
引用本文的文献
1
Safety and efficacy of remote ischaemic preconditioning in diabetic kidney disease: a pilot randomised, parallel-arm, sham-controlled trial protocol.远程缺血预处理在糖尿病肾病中的安全性和有效性：一项试点随机、平行组、假手术对照试验方案
BMJ Open. 2025 Sep 3;15(9):e096851. doi: 10.1136/bmjopen-2024-096851.
2
Comprehensive analysis of cuproptosis-related ceRNA network and immune infiltration in diabetic kidney disease.糖尿病肾病中铜死亡相关ceRNA网络及免疫浸润的综合分析
Heliyon. 2024 Aug 8;10(16):e35700. doi: 10.1016/j.heliyon.2024.e35700. eCollection 2024 Aug 30.
本文引用的文献
1
Sodium-Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting.钠-葡萄糖协同转运蛋白2抑制剂有助于延缓2型糖尿病患者的肾功能损害：一项真实世界临床研究
J Clin Med. 2022 Sep 6;11(18):5259. doi: 10.3390/jcm11185259.
2
Therapeutic Advances in Diabetic Nephropathy.糖尿病肾病的治疗进展
J Clin Med. 2022 Jan 13;11(2):378. doi: 10.3390/jcm11020378.
3
Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy.花生四烯酸代谢环氧合酶途径中的基因变异与类二十烷酸水平及糖尿病肾病风险相关。
J Clin Med. 2021 Sep 2;10(17):3980. doi: 10.3390/jcm10173980.
4
GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Physiology to Clinical Outcomes.糖尿病肾病中的胰高血糖素样肽-1受体激动剂：从生理学到临床结局
J Clin Med. 2021 Aug 31;10(17):3955. doi: 10.3390/jcm10173955.
5
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes.成纤维细胞生长因子23失衡在糖尿病发生发展中的病理生理意义
J Clin Med. 2021 Jun 11;10(12):2583. doi: 10.3390/jcm10122583.
6
Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease.磁共振成像（MRI）在糖尿病肾病无创评估中的作用展望
J Clin Med. 2021 Jun 2;10(11):2461. doi: 10.3390/jcm10112461.
7
How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR.如何评估糖尿病肾病的进展？从蛋白尿到肾小球滤过率。
J Clin Med. 2021 Jun 5;10(11):2505. doi: 10.3390/jcm10112505.
8
Urinary Extracellular Vesicles for Diabetic Kidney Disease Diagnosis.用于糖尿病肾病诊断的尿液细胞外囊泡
J Clin Med. 2021 May 11;10(10):2046. doi: 10.3390/jcm10102046.
Zotero 插件